Rynki

Twoje finanse

Biznes

Forum

SOPHARMA AD: Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds

Spis treści:

1. REPORT

reklama

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
SFA capital increase price correction 10072025 EN espi.pdf  (REPORT)

przewiń, aby zobaczyć całą tabelę
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 81 / 2025
Date of issue: 2025-07-10
Short name of the issuer
SOPHARMA AD
Subject
Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds
Annexes
File Description
SFA capital increase price correction 10072025 EN espi.pdfSFA_capital_increase_price_correction_10072025_EN_espi.pdf Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds

przewiń, aby zobaczyć całą tabelę
SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

przewiń, aby zobaczyć całą tabelę
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-07-10 Ognian Donev Executive Director
Źródło: Komunikaty spółek (ESPI)
powiązane
polecane
najnowsze
popularne
najnowsze
bankier na skróty